Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05233436
Title PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer

lung non-small cell carcinoma

stomach cancer

Advanced Solid Tumor

transitional cell carcinoma

gastroesophageal junction adenocarcinoma

head and neck squamous cell carcinoma



PF-06801591 + PF-07265028

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.